PMID: DOI: To review the 20 years of experience at M. Anderson Cancer Center with a combined-modality approach against inflammatory breast carcinoma. A total of patients with inflammatory breast carcinoma were treated in the past 20 years at M. Anderson Cancer Center by a combined-modali
To describe a large cohort of women with non-puerperal inflammatory breast and to identify characteristics of inflammatory breast cancer. All patients consulting for inflammatory breast syndrome in the breast unit of our tertiary University hospital between September and December were prospectively included. We excluded women who were pregnant or in the postpartum period. Patients underwent systematic clinical examination and imaging breast ultrasonography and mammography. A biopsy was performed if the clinician suspected a malignant lesion of the breast.
Inflammatory breast cancer is a rare but aggressive type of breast cancer that carries a poorer rate of survival than other types of breast cancer. The cancerous cells move rapidly throughout the breast and clog the lymph vessels in the skin, causing the breast to look swollen, red, itchy or inflamed. It's often mistaken for a rash or infection and many women are initially treated with antibiotics or steroids. The average age for women to develop breast cancer is Weight is also a factor, since women who develop IBC tend to be overweight or obese.
Our specialists work together, and with you, to create a personalized treatment plan tailored to your unique medical needs. Our specialized program in IBC — the only program of its kind in the Northeast — includes breast cancer surgeons, medical oncologists, and radiation oncologists who have specific expertise in treating IBC. Our dedicated research program includes research scientists and clinicians who meet regularly to discuss challenging cases and together, develop research programs to address these challenges. This enables us to provide a personalized approach to care for our patients diagnosed with IBC. We welcome the opportunity to offer a second opinion and can partner with your local oncologist to review your options at any stage of your treatment.